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Abstract 
Background: A transient ischaemic attack (TIA) and minor stroke are 
medical emergencies and often a warning sign of future strokes if 
remain untreated. Few studies have investigated the long-term 
psychosocial effects of TIA and minor stroke. Secondary prevention 
and medical management are often the primary focus with limited 
access offered for further psychosocial support. Psychoeducational 
interventions can provide education and advice to people with 
physical health conditions and, with suitable tailoring, could be 
appropriate for people after TIA and minor stroke. This study aims to 
develop a group psychoeducational intervention for people after TIA 
and minor stroke and to test whether it is acceptable and feasible. 
Methods: This mixed-methodology study involves two phases: Phase 
1) A qualitative study to determine the content of a suitable 
intervention; Phase 2) A single-centre feasibility randomised 
controlled trial to evaluate the acceptability of this intervention. The 
overall study has ethical approval. Stroke survivors have been involved 
in designing and monitoring the trial. The aim is to recruit 30-40 
participants from a Stroke/TIA Service, within 6 months following their 
diagnosis. Participants will be randomly allocated to either the usual 
care control group or the intervention group (psychoeducational 
programme). The programme will consist of six group sessions based 
on providing education, psychological and social support. The primary 
outcomes will relate to the feasibility aims of the study. Outcomes will 
be collected at 3 and 6 months to assess mood, quality of life, 
knowledge and satisfaction, and resource use. 
Discussion: There is a need to develop and evaluate effective 
interventions that enhance the education provided to people after TIA 
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and minor stroke and to promote their psychosocial wellbeing. 
Findings will indicate the acceptability of the intervention and 
parameters needed to conduct a definitive trial. 
Registration: ClinicalTrials.gov ID NCT02550392; registered on 15 
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Introduction
Background and rationale
A transient ischaemic attack (TIA), also referred to as a 
‘mini-stroke’, is characteristically a brief and sudden episode 
of focal neurological dysfunction with clinical symptoms that 
typically resolve completely within 24 hours1. A ‘minor stroke’ 
is a term used for stroke patients with mild and non-disabling 
symptoms, but there is considerable variation between studies 
in the criteria used to define a minor stroke2. The National 
Institute of Health Stroke Scale is often used to define a minor 
stroke as a score of ≤3 at the time of initial assessment3.
More than half of all cases of stroke are patients who have 
experienced a TIA or minor stroke4 and considered high risk 
for a subsequent major stroke. Typically, it is assumed that 
TIA and minor stroke patients are expected to make a full 
recovery and to experience only minimal or no functional 
deficits5. However, the Stroke Association has recently 
published a brief report stating that around 70% of people 
with a TIA had reported long-term effects (i.e., memory loss, 
poor mobility, problems with speech and understanding) and 
60% of people reported having been affected emotionally by 
their TIA experience6.
To date, very few studies have addressed the long-term impact 
of TIA and minor stroke, but evidence suggests that patients 
report experiences of certain psychosocial difficulties affect-
ing their quality of life7–9. Currently, secondary prevention 
is the predominant focus of TIA management, and patients 
presenting with no visible or minor impairments are not typi-
cally offered rehabilitation follow-up support or access to 
multidisciplinary stroke services10–12.
Emerging evidence suggests that the psychosocial effects of TIA 
and minor stroke often remain unrecognised and untreated. Psy-
chosocial effects such as anxiety, depression and anger have 
been investigated13–16, but only a few studies have actually 
looked at these emotional effects post-TIA17–20. Regarding the 
risk of depression post-TIA, some studies have found a similar 
association following a stroke21,22. It has been reported that 
TIA patients have similarly high rates of depression (21%) 
and anxiety (29%) as those with stroke from a large regional 
stroke registry study23. Findings from recent systematic 
reviews report TIA patients and minor stroke patients may 
experience residual effects such as depression, fatigue and cog-
nitive difficulties24,25 and anxiety26. Typical emotional difficul-
ties described by TIA patients have been sadness, frustration, 
worries for an uncertain future and loss of confidence27,28.
Psychosocial difficulties can significantly affect the quality of 
life for those following a TIA or minor stroke29 and patients 
are less likely to adhere to secondary prevention precau-
tions. A qualitative study30 found that the experience of a TIA 
can reduce individuals’ quality of life despite the short-term 
nature of their symptoms. Recently, a service evaluation pub-
lished findings suggesting that there was a considerably high 
proportion of TIA and minor stroke patients with clinically 
significant levels of depression and anxiety compared to a 
healthy control group31. Programmes that have included healthy 
lifestyle counselling and exercise for cardiac rehabilitation 
have shown to be beneficial and could potentially be adapted for 
TIA and stroke patients32,33.
Despite some encouraging evidence to promote emotional 
well-being for people after stroke34,35, it continues to remain 
unclear what support could be offered to reduce distress and to 
promote adherence to secondary prevention. To date there have 
been no studies that have designed and tested an intervention 
offering education to address psychosocial difficulties following 
a TIA and minor stroke.
According to the NHS Improvement Stepped Care Model for 
Psychological Care in Stroke36, using a time-limited interven-
tion could potentially allow a large number of individuals to 
access appropriate services which could improve their qual-
ity of life and stroke rehabilitation outcomes. Self-help leaflets, 
support groups, signposting, provision of information and 
other low-level interventions may be considered more appro-
priate for adjusting to a TIA/minor stroke diagnosis37,38. A 
demand for low-level interventions within physical healthcare 
settings has been increasing since the National Institute of 
Clinical Excellence recommendations for Improving Access in 
Psychological Therapies39.
Access to these interventions are currently limited and mainly 
targeted at patients with mental health problems. For an 
intervention to be affective and suitable for TIA and minor 
stroke survivors, content and delivery will require tailoring 
towards their needs.
Psychoeducation is a potential approach which necessitates 
the provision of information and self-help strategies that can 
empower individuals to manage and cope with their difficulties40. 
Psychoeducational interventions have already been effec-
tively delivered in patients with physical illnesses40, and in 
stroke family caregivers41. Such interventions can be brief and 
delivered in a group setting to address cost-effectiveness and 
social support42. This evidence justifies greater focus on the 
psychosocial impact of TIA/minor stroke and development of 
an appropriate intervention.
Research aim and objectives
The aim of this research is to develop a time-limited psych-
oeducational intervention that can be delivered in a group 
format for people with TIA and minor stroke and to evaluate 
the acceptability and feasibility of a randomised controlled trial 
(RCT). A qualitative study with people after TIA/minor stroke 
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and expert clinicians and researchers will be initially conducted 
to help develop the psychoeducational intervention (Phase 1). 
This protocol mainly describes the single-centre feasibility 
RCT (Phase 2) to determine the acceptability of the proposed 
intervention and the parameters to design a definitive trial.
Primary objective. The primary objective is to determine 
whether it is feasible to conduct a RCT to evaluate a group 
psychoeducational intervention for people after TIA and minor 
stroke.
Secondary objectives. The secondary objectives are to test 
the integrity of the study protocol, such as the methods of 
data collection, randomisation procedures and the blinding of 
independent assessors.
•    Can we identify participants willing to be randomised?
•    Consent and drop-out rates
•    Appropriateness of inclusion/exclusion criteria
•    Can we deliver the intervention as planned?
Figure 1. OPTIMISM Study Flowchart.
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•    Can we retain participants in the study?
•    What are the most relevant outcome measures?
Methods and analysis
Study design and setting
The OPTIMISM study has two distinct phases. Phase 1 
(Qualitative Study), outlined in Figure 1, focused on the devel-
opment of the intervention. Phase 2 (Feasibility Trial), described 
here in further detail, focuses on delivering the intervention 
within a single-centre feasibility RCT. The feasibility trial 
protocol methods adhere to the Standard Protocol Items 
Recommendations for Interventional Trials (SPIRIT) guidelines 
for the reporting of study protocols43 (see Reporting guidelines).
The feasibility RCT is a parallel group, two-arm trial with a 
1:1 allocation ratio of a group-based psychoeducational inter-
vention versus a usual care control. We will adhere to the 
recommendations and ethical considerations proposed by the 
Standard Protocol Items for Randomized Trials (SPIRIT)43 
statement guidelines. Participants will be people diagnosed 
with TIA and minor stroke recruited from a Stroke/TIA Service.
Participants
The timeline and proposed flow of participants through the 
feasibility trial (Phase 2) is shown in Figure 1. Participant 
information materials are available as Extended data44.
The inclusion criteria are as follows: 
•    Aged 18 years or over
•     Have a confirmed diagnosis of first or recurrent TIA 
or minor stroke
•    Are independent with activities of daily living after 
diagnosis
•    Are identified within 6 months following diagnosis of 
TIA or minor stroke
•    Able to provide informed consent
Exclusion criteria are as follows: 
•    Are not able to communicate in English
•    Have a diagnosis of dementia prior to the TIA/minor 
stroke that would impact their ability to complete base-
line questionnaires and to participate in group sessions 
(based on self-report by patient/carer and subsequently 
confirmed by checking medical records).
•    Are receiving psychological interventions for mental 
health problems immediately prior to their diagnosis 
of TIA/minor stroke.
•    Have visual (blindness) or auditory (deafness) impair-
ments that would impact on their ability to complete 
baseline questionnaires.
•    Have cognitive or communication difficulties that 
would impact on their ability to complete baseline 
questionnaires and to participate in group sessions.
Intervention development
Phase 1 (Qualitative Study) will involve focus groups or indi-
vidual interviews to explore the views of both people with 
TIA/minor stroke and experts working clinically or conduct-
ing research with people with TIA/minor stroke. Service users 
and experts will be asked to highlight the most important 
difficulties faced after TIA and minor stroke. A topic guide with 
open-ended questions will be used to guide the interview proc-
ess. Data collection and sample size will be determined by 
saturation in themes identified. Results will be analysed using 
thematic analysis to determine the content of an intervention 
for people after TIA and minor stroke.
The intervention will be focused on providing education, 
advice and support within the first six months following 
a TIA and/or minor stroke diagnosis. It will be designed to 
help individuals to identify knowledge and skills to promote 
adjustment, coping and healthier lifestyles.
For each session there will be a presentation containing infor-
mation about a topic and activities to aid group discussion. 
Each session will be facilitated by visual aids such as pres-
entation slides and flipcharts. The topics will be shaped by 
findings from the Phase 1 Qualitative Study. Activities 
during and in-between group sessions will be introduced to 
encourage participants to practice and skills learnt.
Participant workbooks for each session and a facilitator work-
book for the group programme will be developed by the 
research team (see Figure 1). These workbooks will support 
the intervention delivery and will be further developed after the 
end of the feasibility trial. The OPTIMISM group intervention 
programme will be described based on the Template for Inter-
vention Description and Replication (TIDieR) checklist45 
(see Reporting guidelines).
Intervention and comparator
Participants will be randomised after consent and baseline 
assessments to the intervention or usual care control. 
•    Control group: Usual care including all services routinely 
available to them.
•    Intervention group: Usual care plus a group intervention 
based on a psychoeducational framework. This programme 
will be offered in 6 sessions over 2 months. Sessions will be 
delivered face to face in a small group of participants. The 
intervention will be delivered in a suitable place according 
to the availability of space and access for participants. It will 
be facilitated by an assistant psychologist or a trained profes-
sional with matched skills and competences to deliver low-
level group interventions. The group facilitator will receive 
further training from members of the research team 
responsible for the development of the intervention. Each 
session will last approximately 2 hours and will include 
a 15-minute comfort break with refreshments, which will 
allow participants to socialise. Each session will focus on 
providing information about different topics and on devel-
oping problem-solving skills to cope with physical and 
psychosocial difficulties following a TIA or minor stroke.
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Outcomes
Primary outcome measures will mainly pertain to the fea-
sibility aims of the study. Specifically, we are testing the 
feasibility of the trial and the tolerability and acceptability 
of delivering the intervention, study attrition, completing 
the trial and collecting valid and reliable data. This will be 
with the aim to determine the key parameters for conducting 
a larger definitive trial. The feasibility outcome measures 
are: 
•    Feasibility of recruiting TIA and minor stroke patients 
to a group psychoeducational intervention (rates of 
cognitive/mood difficulties, stroke severity, recruitment, 
providing consent, completing intervention, and returning 
outcome questionnaires).
•    Recruitment and exclusion rates (how many patients 
eligible, approached and how many consented, or 
excluded).
•    Completion rates for those who entered into the trial 
(how many completed the intervention/number of 
sessions attended, how many completed and returned 
the follow-up assessments by post, how many follow-up 
assessments required telephone reminders and/or 
face-to-face appointment).
At baseline we will collect sociodemographic details of par-
ticipants including age, gender, ethnicity, employment, living 
arrangements and any relevant medical information (e.g., type 
of stroke, stroke classification etc).
Measures to be completed face-to-face at baseline after informed 
consent: 
•    TIA/stroke severity (NIHSS)46
•    Cognition (Oxford Cognitive Screen (OCS))47
•    Mood (General Health Questionnaire (GHQ-30); Patient Health 
Questionnaire-2 (PHQ-2))48,49
•    Quality of life (EuroQuol-5D-5L (EQ-5D))50
•    Knowledge & feedback questionnaire based on one 
previously published51
•   Resource Use questionnaire
Measures to be completed by post at 3 and 6 months after 
randomisation: 
•    Mood (GHQ-30; PHQ-2)
•    Quality of Life (EQ-5D-5L)
•    Knowledge & feedback questionnaire
•    Resource use questionnaire
Sample size and recruitment strategy
For the qualitative study (Phase 1), a minimum of 10 people 
with TIA or minor stroke and at least six experts will be inter-
viewed. The sample size will be determined by data saturation 
in themes. For the feasibility trial (Phase 2) no formal 
sample size is required. However, a sample size of 30 patients 
or greater is considered adequate to estimate key parameters 
to inform the design of a definite trial52,53. We aim to recruit a 
sample size of 30–40 participants (n=15–20 per group). Recruit-
ment difficulties may affect progress and sample size; however, 
the research team has extensive experience in conducting 
feasibility trials.
The trial opened for recruitment in July 2018 and will be 
open for recruitment until June 2019. Participants will 
be enrolled into the study by a member of staff from the 
Clinical Research Network (CRN) or a member of the research 
team. The CRN/research staff will visit the Stroke wards and 
TIA clinics to provide information about trial to potential 
participants. If they wish to take part, then their permission will 
be sought to be contacted again by the CRN/research team. 
A pre-paid envelope will be provided to anyone who wish to 
return a reply slip with their contact details by post.
The process for obtaining participant informed consent will 
be in accordance with the Research Ethics Committee (REC) 
guidance, and Good Clinical Practice (GCP). Following a full 
explanation of the study, the participant will be required to 
provide informed written consent before they can participate. 
Model consent materials are available as Extended data44.
Randomisation procedure and blinding
Randomisation to each arm on a 1:1 basis and once there 
are 8–12 individuals who have consented and who are able to 
attend the same therapy group (should they be randomised 
to receive it). Randomisation will be conducted using a 
computer-generated randomisation list that will be held on a 
secure server and overseen by an independent member of the 
research team. 
It is not possible for the participants or person delivering the 
intervention to be blind to the group allocation. The research-
ers completing outcome assessments at 3 and 6 months after 
randomisation will be blinded and will not be involved in 
any other aspect of the trial.
Data collection, management and analysis
Data will be collected on a paper-based data collection 
form designed specifically for each phase of the study 
and will subsequently be entered onto a secure electronic 
database. Each participant will be assigned a trial identity code 
number for use on study documents and databases.
When data collection is completed, a data quality check will be 
conducted, and the proportion of missing items will be exam-
ined. Analysis of the outcome data will be conducted on an 
intention to treat basis and will be presented using summary 
statistics. Any differences between the two arms will be cal-
culated at baseline and 6-month follow-up, along with 95% 
confidence intervals. The findings will be used to inform power 
and sample size calculations for a future definitive study and 
to determine appropriateness of these measures. All study 
data will be kept strictly confidential and stored in a secure 
and locked office, and on password-protected databases.
Page 6 of 18
AMRC Open Research 2020, 2:24 Last updated: 07 AUG 2020
Feasibility of completing the intervention
In order to assist in assessing acceptability of the interven-
tion we will provide all the intervention participants with a 
feedback questionnaire during their final session to gather 
information on appropriateness of timing, duration and frequency 
of sessions.
Tolerability will be captured by the proportion of partici-
pants who withdraw or decline the intervention or any sessions 
and the reasons for this. Any adverse events apportioned to be 
as a result of participating in the intervention will be reported.
The integrity of the study protocol will be examined by how 
many participants complete the study, percentage of miss-
ing data, percentage of people who complete questionnaires, 
percentage of people who complete each outcome measure at 
3- and 6-month follow-ups, and calculation of the cost of running 
the study.
PPI
PPI is integrated in all stages of the project, including for 
example the design and conduct of the intervention and 
suggestions in relation to all study materials. During Phase 1, 
PPI will be utilised to establish whether the study is both feasi-
ble and practical and whether the choice of the proposed inter-
vention is something that would be well received by participants. 
PPI will also contribute to the dissemination of research 
findings. By choosing to include PPI in the research 
process we will ensure that the information provided to the 
study participants is user friendly, informative and written in lay 
language. This will help to enhance the recruitment and retention 
of participants to different stages of the project.
Ethics and dissemination
The study is approved by the UK NHS Health Research 
Authority (East Midlands- Nottingham 1 Research Ethics Com-
mittee, ref 15/EM/0453) and the Research & Development 
department of the NHS participating site. This paper reports 
on the study protocol version 4.0, dated 17th May 2018. We 
will conduct our study in line with the Declaration of 
Helsinki54 and according to the principles of GCP55. The sponsor 
for this study is the University of Nottingham, King’s Meadow 
Campus, Nottingham, UK.
Any important protocol amendments will be reported to the 
Health Research Authority, will be registered at ClinicalTrials.
gov and will be communicated to the participating site and study 
sponsor. A Trial Steering Committee with independent members 
will meet to assist in guiding and supervising the project team.
Participants will be informed that they are free to withdraw 
at any time without affecting their future care. Any data col-
lected before their withdrawal may still be used in analysis. For 
participants who cannot attend all group intervention sessions, 
this will be recorded as an outcome. However, they will still be 
asked if they do not wish to receive the postal outcome measures. 
The occurrence of adverse events as a result of participation 
within this study is not expected, since the trial only involves 
a low risk psychological intervention that will be designed 
to improve outcomes and ease distress, and therefore no 
adverse event data shall be collected. If a participant is 
identified as suicidal, then their GP will be informed and the 
usual clinical procedures will be followed by their clinical team.
We plan to disseminate our findings by presenting results at 
national and international stroke and rehabilitation confer-
ences. The RCT results will also be submitted for publication 
to an international, peer-reviewed journal. We will provide trial 
participants with a lay summary of the findings at the end of the 
study if requested. Findings may be further publicised by the 
university, hospital, funder websites and publications.
Trial status
Recruitment on the participating site closed on 30th June 2019 
and the overall trial was completed on 31st January 2020.
Data availability
Underlying data
No underlying data are associated with this study.
Extended data
Figshare: Optimising Psychoeducation for Transient Ischae-
mic Attack and Minor Stroke Management (OPTIMISM): 
Protocol for a Feasibility Randomised Controlled Trial. 
https://doi.org/10.6084/m9.figshare.c.5019200.v144
This project contains the following extended data: 
•    OPTIMISM Research Protocol v4.0, dated 17.05.18
•    OPTIMISM Phase 2 Participant Information Sheet 
v3.0, dated 17.05.18
•    OPTIMISM Phase 2 Participant Consent Form v3.0, 
dated 17.05.18
•    OPTIMISM Phase 2 Poster Information Leaflet v1.0, 
dated 09.11.15
•    OPTIMISM Invitation Reply Slip v1.0, dated 21.09.15
•    OPTIMISM Intervention Outline v2.0, dated 17.05.18
The OPTIMISM participant or facilitator workbooks are 
not currently available publicly as the trial results are not 
yet published. For further details regarding the content of 
the intervention, please contact the corresponding author 
(eirini.kontou@nottingham.ac.uk).
Reporting guidelines
SPIRIT Checklist for Optimising Psychoeducation for Transient 
Ischaemic Attack and Minor Stroke Management (OPTIMISM): 
Protocol for a Feasibility Randomised Controlled Trial. https:// 
doi.org/10.6084/m9.figshare.c.5019200.v144.
TIDieR Checklist for Optimising Psychoeducation for 
Transient Ischaemic Attack and Minor Stroke Management 
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(OPTIMISM): Protocol for a Feasibility Randomised Controlled 
Trial. https://doi.org/10.6084/m9.figshare.c.5019200.v144.
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Summary of Paper:
This paper describes the protocol for a completed two-stage study comprising the 
development (phase I) and single centre feasibility randomised controlled trial (phase II) of 
a 12-hour, psycho-education intervention over two months, for groups of people with TIA or 
minor strokes. The first phase of the research was a qualitative study to develop materials 
for the psychoeducation group from thematic analysis of focus group data from people with 
TIA or minor stroke and experts in the field. The second phase of the study, the main focus 
of the paper, tested the feasibility of the psychoeducation group and a full trial comparing 
the impact of the group to treatment as usual, on measures of knowledge, mood, quality of 
life and resource usage.  
 
○
Study Rationale and Objectives:
The rationale and objectives for the study are clearly described. This is an important area for 
research as TIA and minor strokes are estimated to affect 15–83 patients per 100 000 
population globally (Barton et al., 20171) with 18-20% risk of stroke within 90 days 
(Gommans et al., 20092; Heron et al., 20173) and residual difficulties with fatigue, cognition, 
communication and mood reported (Moran et al., 20144). Although psychoeducation 
interventions have been found to benefit stroke survivors and caregivers (Cheng et al., 2018
5; Ostwald et al., 20146) research has previously been lacking on the potential benefits of 
psychoeducation for people after TIA or minor stroke. 
 
○
Design:
The study is well-designed and clearly reported. The paper outlines the trial design (parallel 
groups), randomisation (independently overseen computer generated randomisation), 
allocation ratio (1:1), blinding (outcome assessment) and the process for testing fidelity to 
the intervention. 
 
○
It will be good to understand what constitutes treatment as usual (e.g. hours of input, from ○
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whom, and to what extent this includes support and education) in the report of the study 
findings. 
 
Methods:
Sufficient details of the methods are provided in the paper and additional information to 
allow replication of the feasibility trial. Eligibility criteria, consent process, measures used, 
timepoints (before, 3 and 6 months after, randomisation) and group size, frequency and 
duration are all outlined clearly. 
 
○
In the report on the findings of the feasibility trial, more information on recruitment and the 
setting and which locations' data were collected will be helpful.    
 
○
The eligibility criteria permitted the feasibility of a trial to be tested without confounding 
findings with significant sensory, cognitive or communication disorders or mental health 
difficulties requiring treatment immediately prior to TIA or minor stroke. As cognitive and 
communication difficulties are found after TIA or minor stroke (Moran et al., 20144) and 
serious mental illness is associated with cardiovascular risk (Correll et al., 20177) it will be of 
interest at a later point, to know if and how the intervention can be adapted for a broader 
client group. 
 
○
The measures selected are reliable, valid and cover a range of clinically important 
outcomes. If possible, the addition of medication adherence to the full trial would be very 
helpful, given the population targeted and their risk of stroke. Many of the measures, 
though unfortunately not the GHQ-30, are freely available, which will be important for wider 
implementation should the intervention be supported by the subsequent full trial. 
 
○
Datasets:
As this is a study protocol, no datasets are presented. ○
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Summary of article:
This paper describes the protocol for a qualitative study and feasibility study; the 
manuscript mostly focuses on the latter. The population of interest is TIA/minor stroke 
patients and the research aims to address the lack of psychosocial support for these 
patients through a group psychoeducational intervention. The purpose of the qualitative 
study is to collect data to inform the content of the intervention. The feasibility study aims 
to investigate the feasibility/acceptability of the psychoeducational intervention through a 
single-centre randomised controlled trial design.
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Is the rationale for, and objectives of, the study clearly described?
Yes, the need for an intervention is clearly described with supporting research cited. 
Although psychoeducation is briefly described, it would be useful to have more information 
about what psychoeducation is and why it was chosen as the theory to underpin the 
intervention. 
 
○
The objectives for the feasibility study are clearly described; however, the objectives for the 
qualitative work are less clear. What were the specific objectives of the qualitative work and 
how did this relate to informing the development of the intervention?
○
 
Is the study design appropriate for the research question?
Yes, the outcomes of the feasibility study are designed to measure outcomes relating to 
feasibility and acceptability of delivering the intervention and the design of a RCT to test the 
intervention. 
 
○
Are sufficient details of the methods provided to allow replication by others? 
The methods are clearly presented, below are some points for clarification:
Although the manuscript predominantly focuses on the feasibility study, it would be helpful 
to have more information about the intervention development phase. Other than 
identifying topics for the intervention sessions, how will the qualitative work be used to 
inform the development of the intervention? The overall structure of the intervention 
appears to be predetermined, i.e. 6 sessions over 2 months; small groups with a facilitator; 
topics for each session and a workbook. How was this structure decided upon, why were 6 
sessions chosen? How was PPI used at the development stage? 
 
○
There could be more details about the design of the qualitative study included without 
adding too much to the word count. For example: where will participants be recruited from; 
how many 1-1 interviews vs focus groups; who will conduct the interviews/focus groups; 
who will analyse the transcripts; what software will be used to manage the data? See 
Consolidated criteria for reporting qualitative research (COREQ) guidelines. 
 
○
How was minor stroke defined? 
 
○
One of the feasibility study objectives is “What are the most relevant outcome measures”, 
how will this be determined?
○
  
Are the datasets clearly presented in a useable and accessible format?
This is a protocol; therefore, does not include datasets.○
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Suzie Wang   
School of Social Sciences, Leeds Beckett University, Leeds, UK 
This is a well-written protocol aiming to address an important research gap on providing 
psychoeducational intervention for people who had TIA/minor stroke. This is also much needed in 
practice for the target population. I enjoyed reading the protocol. The main focus of this protocol 
is on the second phase- a feasibility randomised controlled trial. I have provided the following 
suggestions:
I understand that the study is almost completed. Maybe for future reference, we could have 
a bit more information on the intervention used in the study (e.g., the content and order of 
the sessions). 
 
○
I do wonder how many participants were planned to be in the small group face to face 
intervention session. What might be the rationale for the decision regarding the numbers? 
 
○
It’s great to see that people with aphasia (PWA) is not excluded in participating the study. Is 
there any tailoring made to ensure the intervention is suitable for PWAs? 
 
○
I missed some explanations on the ‘usual care’ in the setting. 
 
○
It would be great if we could see the participants feedback questionnaire in the protocol. 
 
○
I am slightly confused about the PPI in Phase 1, I assume members in this PPI did not 
participate in the Phase 1 focus group study.
○
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Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: psychosocial interventions for stroke, stroke secondary prevention
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard.
Author Response 08 Jul 2020
Eirini Kontou, University of Nottingham, Nottingham, UK 
Thank you for your encouraging and helpful review. We agree that involving people with 
aphasia in stroke studies is important, however we did not foresee that people with TIA and 
minor stroke would experience communications difficulties that could affect their 
participation in the intervention. PPI members were consulted about the presentation and 
language in the participant workbooks. With regards to additional information on the 
intervention, please note that we have included in the OPTIMISM protocol the Template for 
Intervention Description and Replication (TIDieR) checklist v1.0. figshare. Online resource. 
https://doi.org/10.6084/m9.figshare.12473237.v1 We will follow your suggestion of 
including a description of usual care at the participating site in the results paper. We will 
consider including the feedback questionnaire responses of the participants who received 
the intervention when preparing future articles and presentations. This is not included in 
the protocol as it pertains detailed questions in relation to the content of the intervention. 
We would like to clarify that Phase 1 (Qualitative Study) invited participants who were 
interested to take part and agreed to sign a consent form. These were not the same as the 
PPI members or participants in Phase 2 (Feasibility Trial). Thank you for taking the time to 
review this protocol article.  
Competing Interests: No competing interests were disclosed.
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Terry J. Quinn   
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK 
Dr Kontou and collaborators offer a protocol for their Stroke Association funded program, 
of work looking at a psychoeducational intervention following transient ischaemic attack 
(TIA). 
 
○
This seems a well-designed project in a field where more research is urgently needed. 
 
○
The protocol majors on phase II – a single centre pilot. 
 
○
As this is a protocol for a study that is now complete there is no value in suggesting 
changes to the method of the study (I didn’t think changes were needed anyway). Rather, I 
will limit my comments to those aspects that perhaps need a bit more clarity in the 
description. I would hope this would be helpful to the team when they come to share their 
work as a scientific paper. 
 
○
The target population is TIA. The definition of TIA continues to evolve, and the working 
definition varies across centres depending on access to acute imaging. I think the team 
need to fully operationalise the TIA/minor stroke concept and if they are using a time-
based, rather than tissue-based definition this needs to be justified. I accept that a time-
based definition is still common in most of the UK NHS. 
 
○
As the study is now complete, it would be good to know more about the content of the 
intervention and its delivery. Perhaps this is the focus of an alternative paper. 
 
○
Usual care of TIA/minor stroke varies considerably, and it would be useful to know a little 
more about usual care in the setting of this single centre trial. 
 
○
The ‘Research Aims’ section outlines a series of secondary objectives that are not mentioned 
again in the ‘Outcomes’ section. 
 
○
Feasibility studies are often used to inform whether a full scale trial should be pursued. In 
this case it is useful to pre-specify some ‘go’ and ‘no-go’ criteria around recruitment etc. 
Assuming the team haven’t already started data analysis, there would be opportunity to add 
these progression criteria to this protocol.   
 
○
General Health Questionnaire 30 contains items relating to depression, I wasn’t sure why 
the Patient Health questionnaire 2 was also needed. If the PHQ2 is being used as an initial 
screen to determine need for the longer questionnaire, then there is some recent research 
to support this approach: Levis et al. (20201). 
 
○
Could the feedback questionnaire be included in the protocol? 
 
○
I am assuming there will not be a separate statistical analysis plan publication. So, the 
authors could use the protocol to prespecify how they will handle situations of missing data 
e.g. fully or partially incomplete postal questionnaires. 
 
○
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The description of the patient involvement seemed a bit vague. The research team have a 
great track record in involving stroke survivors in their research, so I would like to see more 
in this section. 
 
○
At times some of the text reads more like an ethics/R&D application, rather than a protocol 
describing a now complete trial. For example rather than outline the various authorities that 
protocol amendments will be sent to, for this final protocol paper, it would be useful to 
actually state if there were any protocol amendments and what they involved.   
 
○
There are many data sharing platforms for stroke and vascular cognitive impairment – once 
primary analyses are complete are the authors going to share data with any of these 
platforms?
○
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Eirini Kontou, University of Nottingham, Nottingham, UK 
Thank you for accepting to review this protocol and your helpful comments. 
 
We are grateful for your suggestions regarding future publications. We will consider 
reporting the protocol amendments required during the trial, the detailed description of PPI 
involvement and the statistical analysis plan in a results paper. 
  
We agree that the definition of TIA is an ongoing issue for studies in this area. As this is a 
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feasibility trial, we aimed to be as inclusive as possible and to recruit people with a 
diagnosis of TIA as confirmed in their hospital medical notes. In line with your suggestion, 
the definitions of TIA and minor stroke will be further clarified when designing a future 
study. 
 
We appreciate that you have drawn our attention to the paper by Levis et al. (2020). The 
PHQ-2 was selected as a brief measure that could be used to screen people when 
diagnosed with TIA/minor stroke and at follow-up. We wanted to explore the acceptability 
of two different mood measures completed and returned by post.     
 
The group feedback questionnaire was designed for the purpose of this study and included 
in the protocol. We would like to note that the final approved ethics/R&D protocol is also 
available here: Kontou et al. (2020): OPTIMISM Research Protocol v4.0 17.05.18. figshare. 
Online resource. https://doi.org/10.6084/m9.figshare.12472361.v1 
  
Thank you once again for taking the time to review this article and your recommendations.  
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